Search the webpage




Dr. Michel Janicot holds a Ph.D. degree in Biochemistry (Molecular and Cellular Biology) from the University of Paris VII (France) after which he was Postdoctoral Fellow at The Johns Hopkins University (Baltimore, MD. USA). Dr. Janicot has over 25 years hands-on experience in preclinical and early clinical pharmaceutical drug development in increasing leadership roles at Rhone-Poulenc Rorer (Sanofi) and subsequently at Janssen (Johnson & Johnson).

Since 2012, Dr. Janicot is the founder and Managing Director of JMi ONConsulting, a firm specialized in providing consulting services and guidances for R&D programs in the field of Oncology, Inflammation, Immunology, Fibrosis and Ophthalmology. Under this business umbrella, Dr. Janicot is part-time management team member (acting CSO/CDO) in various companies. He is also co-founder and Board member of aPODD, a non-profit foundation focusing on Pediatric Oncology Drug Development.



New Board of Directors announced

Experimentica Ltd., a global contract research organization that specializes in preclinical models for ophthalmic diseases, is pleased to announce its ... Read More

New insights to the supporting mechanism of fluid management in the neural retina

Angiopoietin-4 was identified as the first growth factor having a venous-specific function in the mouse retina, according to a publication ... Read More

Experimentica Ltd. opens a new R&D site in Lithuania

The investment totaling €1.6 million was supported, in part, by a competitive award “Smart FDI” (project no. 01.2.1-LVPA-T-848-01-005) under the ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!